Solesence, Inc.
SLSN
$1.15
-$0.01-0.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.11% | -13.42% | 56.78% | 49.15% | 60.85% |
| Total Other Revenue | -62.82% | -20.99% | -20.33% | -47.92% | -47.12% |
| Total Revenue | -0.67% | -13.45% | 56.06% | 48.21% | 56.87% |
| Cost of Revenue | -7.67% | 4.30% | 55.62% | 78.80% | 29.99% |
| Gross Profit | 24.15% | -44.77% | 57.14% | -5.53% | 487.26% |
| SG&A Expenses | 16.60% | 58.69% | 64.68% | 35.21% | 19.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.85% | 12.51% | 53.75% | 64.09% | 29.09% |
| Operating Income | 183.41% | -124.42% | 82.43% | -76.96% | 88.24% |
| Income Before Tax | 53.47% | -136.78% | 257.13% | -91.04% | 84.40% |
| Income Tax Expenses | -239.65% | -- | -- | -- | 3,683.33% |
| Earnings from Continuing Operations | 129.21% | -136.78% | 211.57% | -91.04% | 73.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 129.21% | -136.78% | 211.57% | -91.04% | 73.78% |
| EBIT | 183.41% | -124.42% | 82.43% | -76.96% | 88.24% |
| EBITDA | 8,040.00% | -116.21% | 66.54% | -64.16% | 100.30% |
| EPS Basic | 128.75% | -136.47% | 151.66% | -93.53% | 81.35% |
| Normalized Basic EPS | -310.00% | -136.40% | 189.36% | -93.40% | 88.76% |
| EPS Diluted | 100.00% | -150.00% | 280.00% | -93.53% | 81.35% |
| Normalized Diluted EPS | -296.67% | -137.36% | 189.01% | -92.71% | 88.76% |
| Average Basic Shares Outstanding | 0.79% | 0.90% | 23.87% | 33.08% | 41.07% |
| Average Diluted Shares Outstanding | 3.99% | -1.99% | 23.63% | 25.15% | 41.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |